Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| macrophage | 25 studies | 33% ± 19% | |
| classical monocyte | 16 studies | 24% ± 8% | |
| B cell | 16 studies | 21% ± 6% | |
| non-classical monocyte | 15 studies | 24% ± 8% | |
| microglial cell | 12 studies | 47% ± 14% | |
| mast cell | 12 studies | 28% ± 7% | |
| naive B cell | 11 studies | 24% ± 8% | |
| myeloid cell | 11 studies | 35% ± 14% | |
| dendritic cell | 10 studies | 31% ± 10% | |
| conventional dendritic cell | 8 studies | 30% ± 15% | |
| memory B cell | 8 studies | 21% ± 6% | |
| monocyte | 8 studies | 35% ± 15% | |
| oligodendrocyte | 7 studies | 25% ± 9% | |
| GABAergic neuron | 5 studies | 47% ± 19% | |
| fibroblast | 5 studies | 21% ± 7% | |
| endothelial cell | 4 studies | 24% ± 7% | |
| immature B cell | 4 studies | 23% ± 4% | |
| cardiac muscle cell | 4 studies | 19% ± 2% | |
| astrocyte | 4 studies | 36% ± 13% | |
| oligodendrocyte precursor cell | 4 studies | 23% ± 6% | |
| alveolar macrophage | 4 studies | 46% ± 18% | |
| hematopoietic precursor cell | 3 studies | 28% ± 10% | |
| GABAergic interneuron | 3 studies | 19% ± 3% | |
| precursor B cell | 3 studies | 24% ± 2% | |
| mononuclear phagocyte | 3 studies | 30% ± 7% | |
| epithelial cell | 3 studies | 31% ± 13% | |
| retinal ganglion cell | 3 studies | 27% ± 14% | |
| glutamatergic neuron | 3 studies | 60% ± 5% | |
| type II pneumocyte | 3 studies | 23% ± 4% | |
| interneuron | 3 studies | 54% ± 18% | |
| abnormal cell | 3 studies | 19% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| thymus | 100% | 1653.22 | 653 / 653 | 100% | 15.96 | 603 / 605 |
| bladder | 100% | 1585.71 | 21 / 21 | 99% | 12.22 | 500 / 504 |
| breast | 100% | 1399.59 | 458 / 459 | 99% | 16.93 | 1111 / 1118 |
| lung | 100% | 2418.54 | 578 / 578 | 99% | 13.79 | 1145 / 1155 |
| kidney | 100% | 964.03 | 89 / 89 | 99% | 13.30 | 888 / 901 |
| uterus | 100% | 1347.75 | 170 / 170 | 98% | 10.81 | 452 / 459 |
| pancreas | 100% | 884.72 | 327 / 328 | 98% | 13.31 | 175 / 178 |
| stomach | 100% | 1349.23 | 359 / 359 | 97% | 8.72 | 278 / 286 |
| intestine | 100% | 1465.13 | 966 / 966 | 97% | 9.60 | 512 / 527 |
| esophagus | 100% | 969.68 | 1439 / 1445 | 97% | 8.03 | 177 / 183 |
| brain | 96% | 762.25 | 2547 / 2642 | 99% | 8.58 | 701 / 705 |
| adrenal gland | 100% | 2366.17 | 258 / 258 | 96% | 10.76 | 220 / 230 |
| prostate | 100% | 1102.90 | 244 / 245 | 93% | 10.42 | 467 / 502 |
| skin | 100% | 1172.17 | 1807 / 1809 | 91% | 10.65 | 430 / 472 |
| ovary | 100% | 1678.33 | 180 / 180 | 90% | 6.39 | 387 / 430 |
| liver | 97% | 603.05 | 220 / 226 | 74% | 5.17 | 302 / 406 |
| adipose | 100% | 1473.55 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 1483.62 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 11.30 | 29 / 29 |
| spleen | 100% | 2804.15 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 7.85 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 8.40 | 1 / 1 |
| peripheral blood | 99% | 1989.47 | 921 / 929 | 0% | 0 | 0 / 0 |
| heart | 93% | 821.96 | 805 / 861 | 0% | 0 | 0 / 0 |
| muscle | 75% | 302.79 | 603 / 803 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 75% | 5.35 | 60 / 80 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0009313 | Biological process | oligosaccharide catabolic process |
| GO_0036211 | Biological process | protein modification process |
| GO_0006516 | Biological process | glycoprotein catabolic process |
| GO_0043202 | Cellular component | lysosomal lumen |
| GO_0035577 | Cellular component | azurophil granule membrane |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0005537 | Molecular function | D-mannose binding |
| GO_0004567 | Molecular function | beta-mannosidase activity |
| Gene name | MANBA |
| Protein name | Alternative protein MANBA Mannosidase beta beta-mannosidase (EC 3.2.1.25) Beta-mannosidase (EC 3.2.1.25) (Lysosomal beta A mannosidase) (Mannanase) Beta-mannosidase (EC 3.2.1.25) (Lysosomal beta A mannosidase) (Mannanase) (Mannase) |
| Synonyms | MANB1 |
| Description | FUNCTION: Exoglycosidase that cleaves the single beta-linked mannose residue from the non-reducing end of all N-linked glycoprotein oligosaccharides. . FUNCTION: Exoglycosidase that cleaves the single beta-linked mannose residue from the non-reducing end of all N-linked glycoprotein oligosaccharides. . FUNCTION: Exoglycosidase that cleaves the single beta-linked mannose residue from the non-reducing end of all N-linked glycoprotein oligosaccharides. . FUNCTION: Exoglycosidase that cleaves the single beta-linked mannose residue from the non-reducing end of all N-linked glycoprotein oligosaccharides. . |
| Accessions | A0A2R8YCE9 A0A2R8Y524 ENST00000644545.1 ENST00000644159.1 ENST00000505239.1 A0A2R8Y7N1 A0A2R8Y7A0 ENST00000647097.2 ENST00000642252.1 O00462 ENST00000647129.1 ENST00000646727.1 A0A2R8YG98 A0A2R8Y211 D6RA01 ENST00000644965.1 ENST00000511813.1 ENST00000646451.1 A0A2R8Y7A7 ENST00000646311.1 A0A2R8YEC9 E9PFW2 L8E9D5 A0A2R8Y4U7 A0A2R8YE79 ENST00000645558.1 A7LFP5 ENST00000645348.1 |